Case 2, a 29-year-old woman, developed bilateral optic neuritis combined with numbness of the lower extremities as well as bowel and bladder dysfunction after a 22-month use of recombinant interferon alpha-2b for chronic myelogenous leukemia.
bilateral optic neuritis
recombinant interferon alpha-2b
bowel and bladder dysfunction
recombinant interferon alpha-2b
numbness of the lower extremities
recombinant interferon alpha-2b